Elizabeth R. Stirling

发表

Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation

D. Soto-Pantoja, D. Roberts, David R. Soto-Pantoja, 2018, Cancer and Metastasis Reviews.

Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy

S. Soker, Katherine L. Cook, D. Soto-Pantoja, 2022, Scientific Reports.

Metabolomic Analysis Reveals Unique Biochemical Signatures Associated with Protection from Radiation Induced Lung Injury by Lack of cd47 Receptor Gene Expression

Katherine L. Cook, D. Soto-Pantoja, D. Roberts, 2019, Metabolites.

Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response

L. Miller, P. Triozzi, D. Soto-Pantoja, 2022, Journal for immunotherapy of cancer.

806 PD-1 blockade affects inflammation and metabolic flexibility to potentially mediate cardiac immune-related adverse events

P. Triozzi, D. Soto-Pantoja, B. Westwood, 2021, Journal for ImmunoTherapy of Cancer.

Metabolic Implications of Immune Checkpoint Proteins in Cancer

P. Triozzi, D. Soto-Pantoja, Jessica D. Mackert, 2022, Cells.

Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation

D. Soto-Pantoja, D. Roberts, N. Emenaker, 2018, Cancer and Metastasis Reviews.

206 An immune-competent tumor organoid platform to test novel immune checkpoint combinations targeting the receptor CD47 in triple negative breast cancer

L. Miller, S. Soker, A. Skardal, 2020 .

Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progression

G. Lesser, P. Triozzi, D. Soto-Pantoja, 2023, bioRxiv.

Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis

H. Lo, G. Lesser, D. Soto-Pantoja, 2023, bioRxiv.